Cutaneous manifestations in COVID-19


  • Luh P. V. C. Sari Department of Medical Bachelor and Medical Profession, Universitas Udayana, Denpasar, Bali,



COVID-19, Extrapulmonary, Cutaneous, Skin


Despite of primarily infecting the respiratory tract, coronavirus disease 2019 (COVID-19) may have an extensive extrapulmonary clinical manifestations, including the integumen system. Cutaneous manifestations of COVID-19 are polymorphic, hence it can be confused with any other identical lesions caused by other agents. This literature review concludes the cutaneous manifestations which can be found in COVID-19. COVID-19 may manifest as maculopapular rash, urticaria, vesicular lesions, covid toes, and livedo recamosa. Some of these cutaneous manifestations may have a significant prognostic value for diagnosing COVID-19. Although COVID-19 role in the integumen system is poorly understood, proper identification are needed to distinguish these lesions from different etiological agents.  


Author Biography

Luh P. V. C. Sari, Department of Medical Bachelor and Medical Profession, Universitas Udayana, Denpasar, Bali,

Department of Medical Bachelor and Medical Profession


Organization WH. Global surveillance for COVID-19 disease caused by human infection with the 2019 novel coronavirus, Interim guidance. 2020.

Marzano AV, Cassano N, Genovese G, Moltrasio C, Vena GA. Cutaneous manifestations in patients with COVID‐19: a preliminary review of an emerging issue. Br J Dermatol. 2020;183:431-42.

Galván Casas C, Catala A, Carretero Hernández G, Rodríguez‐Jiménez P, Fernández‐Nieto D, Rodríguez‐Villa Lario A et al. Classification of the cutaneous manifestations of COVID‐19: a rapid prospective nationwide consensus study in Spain with 375 cases. Br J Dermatol. 2020;183:71-77.

Organization WH. Weekly operational update on COVID-19. World Heal Organ Geneva, Switz. 2021;1-10.

Organization WH. Coronavirus disease (COVID-19): situation report. 2020;162.

Kementerian Kesehatan Republik Indonesia. Situasi COVID-19.2021.

Recalcati S. Cutaneous manifestations in COVID-19: a first perspective. J Eur Acad Dermatol Venereol. 2020;4:12-8.

Giavedoni P, Podlipnik S, Pericàs JM, Fuertes de Vega I, García-Herrera A, Alós L et al. Skin manifestations in COVID-19: prevalence and relationship with disease severity. J Clin Med. 2020;9:3261.

Mariyath OKR, Samad KA, Devi K, Surya VS, Effeena MD, Ajina M. Atypical maculopapular rash as the initial sign of COVID-19: A case report from a COVID hospital. J Ski Sex Transm Dis. 2021;3:87-90.

Sachdeva M, Gianotti R, Shah M, Bradanini L, Tosi D, Veraldi S, Ziv M et al. Cutaneous manifestations of COVID-19: Report of three cases and a review of literature. J Dermatol Sci. 2020;98:75-81.

Gottlieb M, Long B. Dermatologic manifestations and complications of COVID-19. Am J Emerg Med. 2020;38:1715-21.

Rahimi H, Tehranchinia Z. A comprehensive review of cutaneous manifestations associated with COVID-19. Biomed Res Int. 2020;2020.

Henry D, Ackerman M, Sancelme E, Finon A, Esteve E. Urticarial eruption in COVID‐19 infection. J Eur Acad Dermatology Venereol. 2020.

Hassan K. Urticaria and angioedema as a prodromal cutaneous manifestation of SARS-CoV-2 (COVID-19) infection. BMJ Case Reports CP. 2020;13:e236981.

De Giorgi V, Recalcati S, Jia Z, Chong W, Ding R, Deng Y et l. Cutaneous manifestations related to coronavirus disease 2019 (COVID-19): A prospective study from China and Italy. J Am Acad Dermatol. 2020;83:674-5.

Fernandez‐Nieto D, Ortega‐Quijano D, Jimenez‐Cauhe J, Burgos‐Blasco P, de Perosanz‐Lobo D, Suarez‐Valle A et al. Clinical and histological characterization of vesicular COVID‐19 rashes: a prospective study in a tertiary care hospital. Clin Exp Dermatol. 2020;45:872-875.

Wang CJ, Worswick S. Cutaneous manifestations of COVID-19. Dermatol Online J. 2021;27.

Baeck M, Herman A. COVID toes: where do we stand with the current evidence? Int J Infect Dis. 2021;102:53-5.

Colmenero I, Santonja C, Alonso‐Riaño M, Noguera‐Morel L, Hernández‐Martín A, Andina D et al. SARS‐CoV‐2 endothelial infection causes COVID‐19 chilblains: histopathological, immunohistochemical and ultrastructural study of seven paediatric cases. Br J Dermatol. 2020;183:729-37.

Cappel MA, Cappel JA, Wetter DA. Pernio (chilblains), SARS-CoV-2, and COVID toes unified through cutaneous and systemic mechanisms. In: Mayo Clinic Proceedings. Elsevier. 2021;96:989-1005.

Khalil S, Hinds BR, Manalo IF, Vargas IM, Mallela S, Jacobs R. Livedo reticularis as a presenting sign of severe acute respiratory syndrome coronavirus 2 infection. JAAD Case Reports. 2020;6:871-4.




How to Cite

Sari, L. P. V. C. (2022). Cutaneous manifestations in COVID-19. International Journal of Research in Medical Sciences, 10(3), 772–776.



Review Articles